Annual report [Section 13 and 15(d), not S-K Item 405]

Concentrations

v3.25.4
Concentrations
12 Months Ended
Dec. 31, 2025
Risks and Uncertainties [Abstract]  
Concentrations

Note L – Concentrations

Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue for the year ended December 31, 2025 and 2024. In 2025 and 2024, one party constituted 100% of the Company’s revenue.